Cannabinoid Encyclopedia

Cannabinoid guide

What is SEA?

A clear guide to SEA: what it is, what researchers have studied, how strong the evidence is, and what to know about safety.

Updated July 2026 16 research sources Human and early research

The short answer

SEA, in simple terms

SEA is a cannabinoid-related compound represented in the scientific literature. Researchers study it for possible effects, safety, and how it works in the body. The source set includes human research as well as earlier-stage studies. The evidence does not turn this into one proven benefit, because studies can use different products, doses, routes, people, and outcomes. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about SEA.

Why people look into SEA

What SEA is commonly talked about for

These cards show the questions most represented in this source set. They are not a list of proven benefits, and the evidence label matters as much as the topic name.

  1. Human and early-stage research

    SEA biology, metabolism, physiology, or safety-relevant mechanisms

    Safety research asks how SEA, its dose, route, formulation, and other medications may change risk. The available evidence may not answer the safety question for every product or person. 2

    See research areas

Bottom line: Start with the exact question you care about, then check the study type, product, dose, and outcome before treating a research signal as a real-world effect.

Key takeaways

What to know first

  1. 1

    Research on SEA covers SEA biology, metabolism, physiology, or safety-relevant mechanisms; those areas should not be combined into one claim. 1

  2. 2

    The source set includes human research as well as earlier-stage studies. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What has SEA been studied for?

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Human and early-stage research

SEA biology, metabolism, physiology, or safety-relevant mechanisms

Researchers have examined SEA in connection with SEA biology, metabolism, physiology, or safety-relevant mechanisms. The studies may differ in compound, formulation, dose, route, population, and outcome. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

4 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

4 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

8 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on SEA is not one kind of study. This source set includes 7 animal studies and 4 narrative or expert reviews. 3

The recorded populations or models include animal models (7 sources), people or patients (4 sources), and cells or tissue models (1 source). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is sEA biology, metabolism, physiology, or safety-relevant mechanisms (16 sources). Closely related outcome names can still describe different measurements. 5

The SEA source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.

On this page, this source examines SEA and sEA biology, metabolism, physiology, or safety-relevant mechanisms. 1

Study type
narrative or expert review
Population or model
animal models
Outcome focus
sEA biology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.

On this page, this source examines SEA and sEA biology, metabolism, physiology, or safety-relevant mechanisms. 2

Study type
narrative or expert review
Population or model
animal models
Outcome focus
sEA biology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

human research

Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study.

On this page, this source examines SEA and sEA biology, metabolism, physiology, or safety-relevant mechanisms. 3

Population or model
people or patients
Outcome focus
sEA biology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
human research

narrative or expert review

Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification.

On this page, this source examines SEA and sEA biology, metabolism, physiology, or safety-relevant mechanisms. 4

Study type
narrative or expert review
Outcome focus
sEA biology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury.

On this page, this source examines SEA and sEA biology, metabolism, physiology, or safety-relevant mechanisms. 5

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
sEA biology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on SEA should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Common questions

Questions people ask

What is SEA?

SEA is a cannabinoid-related compound studied across SEA biology, metabolism, physiology, or safety-relevant mechanisms. This page separates those research questions so they are not mistaken for one broad claim. 7

What has SEA been studied for?

The current source set includes SEA biology, metabolism, physiology, or safety-relevant mechanisms. Each area may use different doses, products, routes, populations, and outcome measures. 8

How strong is the research on SEA?

The source set includes human research as well as earlier-stage studies. 9

Is SEA safe?

Safety cannot be answered for SEA without context. Dose, route, formulation, medications, and the person using it can all change risk. 10

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. narrative or expert review; evidence still limited PubMed 23813098 DOI 10.1007/s12035-013-8487-6
  2. 2
    Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. narrative or expert review; evidence still limited PubMed 20353771 DOI 10.1016/j.expneurol.2010.03.022
  3. 3
    Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study. human research PubMed 37578507 DOI 10.1097/j.pain.0000000000003015
  4. 4
    Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification. narrative or expert review; evidence still limited PubMed 26839710 DOI 10.1155/2016/2426398
  5. 5
    Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. narrative or expert review; evidence still limited PubMed 24874648 DOI 10.1016/j.phrs.2014.05.009
  6. 6
    [Anti-inflammatory effect of N-stearoylethanolamine in experimental burn injury in rats]. animal study; preclinical research PubMed 19873884
  7. 7
    [Effects of N-stearoylethanolamine on the emotionality and learning ability of rats]. animal study; preclinical research PubMed 25566671
  8. 8
    [Immunosuppressive characteristics of N-stearoylethanolamine a stable compound with cannabimimetic activity]. animal study; preclinical research PubMed 18710028
  9. 9
    Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. animal study; mechanism-focused research PubMed 12010121 DOI 10.1042/bj20020438
  10. 10
    Exploring the Utility of Hair Endocannabinoids for Monitoring Homeostasis in Bonobos. preclinical research PubMed 33434116 DOI 10.1086/712658
  11. 11
    Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. animal study; mechanism-focused research PubMed 16154384 DOI 10.1016/j.bbalip.2005.08.010
  12. 12
    N-Stearoylethanolamine Exerts Cardioprotective Effects in Old Rats. animal study; preclinical research PubMed 38279735 DOI 10.2174/0118746098275323231226073348
See all 16 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. narrative or expert review; evidence still limited / 1 linked research note PubMed 20353771
  2. Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation. animal study; preclinical research / 1 linked research note PubMed 31881191
  3. Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. narrative or expert review; evidence still limited / 1 linked research note PubMed 24874648
  4. Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. animal study; mechanism-focused research / 1 linked research note PubMed 12010121
  5. High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women. mechanism-focused research / 1 linked research note PubMed 22125609
  6. Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity. mechanism-focused research / 1 linked research note PubMed 23707281
  7. Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study. human research / 1 linked research note PubMed 37578507
  8. High levels of endogenous lipid mediators (N-acylethanolamines) in women with chronic widespread pain during acute tissue trauma. mechanism-focused research / 1 linked research note PubMed 27531672
  9. N-Stearoylethanolamine Exerts Cardioprotective Effects in Old Rats. animal study; preclinical research / 1 linked research note PubMed 38279735
  10. Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification. narrative or expert review; evidence still limited / 1 linked research note PubMed 26839710
  11. [Effects of N-stearoylethanolamine on the emotionality and learning ability of rats]. animal study; preclinical research / 1 linked research note PubMed 25566671
  12. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. narrative or expert review; evidence still limited / 1 linked research note PubMed 23813098
  13. [Immunosuppressive characteristics of N-stearoylethanolamine a stable compound with cannabimimetic activity]. animal study; preclinical research / 1 linked research note PubMed 18710028
  14. [Anti-inflammatory effect of N-stearoylethanolamine in experimental burn injury in rats]. animal study; preclinical research / 1 linked research note PubMed 19873884
  15. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. animal study; mechanism-focused research / 1 linked research note PubMed 16154384
  16. Exploring the Utility of Hair Endocannabinoids for Monitoring Homeostasis in Bonobos. preclinical research / 1 linked research note PubMed 33434116